
During a live event, Pedro Barata, MD, MSc, and participating oncologists discussed how efficacy, tolerability, and clinical evidence inform subsequent-line treatment selection for metastatic clear cell renal cell carcinoma.
Treatment of Refractory Metastatic Renal Cell Carcinoma
A 70-Year-Old African-American Woman with Metastatic RCC
December 2017
June 2018